Global Shift in R&D | GenomeWeb

Global Shift in R&D

A new analysis of global biomedical research and development investments shows that the US is losing some of its dominance, as industry science funding in the US, in particular, has lagged just as countries in Asia and Oceania have been spending more on R&D.

The analysis of global R&D trends between 2007 and 2012, published in the New England Journal of Medicine, found that the US share of global biomedical research spending declined over the last five years from 51 percent to below 45 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.